27.26

10.06% -3.05

After Hours: 28.50 1.24 +4.55%

Parabilis Medicines Inc (PBLS)

Overview News Price History Discussions Forecast

Parabilis Medicines Inc stock is traded at $27.26, with a volume of 1.04M. It is down -10.06% in the last 24 hours and up +0.00% over the past month. Parabilis Medicines Inc s a clinical-stage biopharmaceutical company. It is focused on the development of medicines targeting protein interactions associated with human diseases. It uses a proprietary platform to develop stabilized helical peptide therapeutics, referred to as Helicons, designed to bind and modulate specific proteins. Its flagship product candidate, zolucatetide, targets the interaction between β-catenin and the T-cell factor (TCF) family of transcription factors within the Wnt/β-catenin signaling pathway, which is associated with cell proliferation and differentiation in multiple cancer types.

Previous Close:

$30.31

Open:

$29.86

24h Volume:

1.04M

Relative Volume:

25.93

Market Cap:

$3.33B

Revenue:

Net Income/Loss:

P/E Ratio:

EPS:

Net Cash Flow:

1W Performance:

+0.00%

1M Performance:

+0.00%

6M Performance:

+0.00%

1Y Performance:

+0.00%

1-Day Range:

$26.88

$32.47

1-Week Range:

$26.88

$34.47

52-Week Range:

$26.88

$34.47

Parabilis Medicines Inc Stock (PBLS) Company Profile

Name

Parabilis Medicines Inc

Sector

Healthcare (1109)

Industry

Biotechnology (621)

Phone

Address

Employee

Twitter

Next Earnings Date

null

Latest SEC Filings

PBLS's Discussions on Twitter

Compare PBLS vs VRTX, REGN, ARGX, ALNY, RVMD

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PBLS Parabilis Medicines Inc	27.26	3.33B	0	0	0	0.00
VRTX Vertex Pharmaceuticals Inc	444.93	112.92B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	612.14	64.18B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	893.52	55.57B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	282.85	37.76B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	153.87	32.71B	742.00K	-1.37B	-1.07B	-7.0731